Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2003-07-08
2010-06-08
Carr, Deborah D (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S547000
Reexamination Certificate
active
07732488
ABSTRACT:
The invention relates to a process for decreasing the amount of environmental pollutants in a mixture comprising a fat or an oil, being edible or for use in cosmetics, the fat or oil containing the environmental pollutants, which process comprises the steps of adding a volatile working fluid to the mixture, where the volatile working fluid comprises at least one of a fatty acid ester, a fatty acid amide, a free fatty acid and a hydro-carbon, and subjecting the mixture with the added volatile working fluid to at least one stripping processing step, in which an amount of environmental pollutant present in the fat or oil, being edible or for use in cosmetics, is separated from the mixture together with the volatile working fluid. The present invention also relates to a volatile environmental pollutants decreasing working fluid, for use in decreasing an amount of environmental pollutants present in a fat or oil, being edible or for use in cosmetics. In addition, the present invention relates to a health supplement, a pharmaceutical and an animal feed product prepared according to the process mentioned above.
REFERENCES:
patent: 2126467 (1938-08-01), Hickman et al.
patent: 2146894 (1939-02-01), Hickman
patent: 2180356 (1939-11-01), Hickman et al.
patent: 2349269 (1944-05-01), Hickman
patent: 2985589 (1961-05-01), Broughton et al.
patent: 3082228 (1963-03-01), Sutherland
patent: 3158541 (1964-11-01), Sutherland
patent: 3696107 (1972-10-01), Neuzil
patent: 3706812 (1972-12-01), de Rosset et al.
patent: 3761533 (1973-09-01), Otani et al.
patent: 4061556 (1977-12-01), Reis et al.
patent: 4124528 (1978-11-01), Modell
patent: 4147624 (1979-04-01), Modell
patent: 4156688 (1979-05-01), Zosel
patent: 4352746 (1982-10-01), Bracco et al.
patent: 4377525 (1983-03-01), D'Alelio et al.
patent: 4377526 (1983-03-01), Fujita et al.
patent: 4415554 (1983-11-01), Horrobin
patent: 4526902 (1985-07-01), Rubin
patent: 4554107 (1985-11-01), Takao
patent: 4564475 (1986-01-01), Masaichiro
patent: 4615839 (1986-10-01), Seto et al.
patent: 4623488 (1986-11-01), Takao
patent: 4675132 (1987-06-01), Stout et al.
patent: 4681896 (1987-07-01), Horrobin
patent: 4692280 (1987-09-01), Spinelli et al.
patent: 4758592 (1988-07-01), Horrobin et al.
patent: 4764392 (1988-08-01), Yasufuku et al.
patent: 4792418 (1988-12-01), Rubin et al.
patent: 4804555 (1989-02-01), Marschner et al.
patent: 4956286 (1990-09-01), Macrae
patent: 4956287 (1990-09-01), Suzuki et al.
patent: 4996072 (1991-02-01), Marschner et al.
patent: 5013443 (1991-05-01), Higashidate et al.
patent: 5091117 (1992-02-01), Athnasios et al.
patent: 5106542 (1992-04-01), Traitler et al.
patent: 5130061 (1992-07-01), Cornieri et al.
patent: 5130449 (1992-07-01), Lagarde et al.
patent: 5211812 (1993-05-01), Vielberth et al.
patent: 5243046 (1993-09-01), Traitler et al.
patent: 5316927 (1994-05-01), Zaks et al.
patent: 5340602 (1994-08-01), Hoche
patent: 5374751 (1994-12-01), Cheng et al.
patent: 5436018 (1995-07-01), Massie et al.
patent: 5480787 (1996-01-01), Negishi et al.
patent: 5502077 (1996-03-01), Breivik et al.
patent: 5558893 (1996-09-01), Muraldihara
patent: 5656667 (1997-08-01), Breivik et al.
patent: 5698594 (1997-12-01), Breivik et al.
patent: 5719302 (1998-02-01), Perrut et al.
patent: 5792795 (1998-08-01), Buser et al.
patent: 5945318 (1999-08-01), Breivik et al.
patent: 5948818 (1999-09-01), Buser et al.
patent: 6204401 (2001-03-01), Perrut et al.
patent: 6277405 (2001-08-01), Stamm et al.
patent: 6518049 (2003-02-01), Haraldsson et al.
patent: 2002/0077361 (2002-06-01), Peet et al.
patent: 2003/0077342 (2003-04-01), Maffetone
patent: 2003/0212138 (2003-11-01), Obukowicz
patent: 2004/0210070 (2004-10-01), Kruidenberg
patent: 2005/0171200 (2005-08-01), Calder et al.
patent: 2006/0134303 (2006-06-01), Sondbo et al.
patent: 2006/0148047 (2006-07-01), Haraldsson et al.
patent: 2006/0166935 (2006-07-01), Bryhn
patent: 2006/0211762 (2006-09-01), Rongen et al.
patent: 2007/0036862 (2007-02-01), Rongen et al.
patent: 2009/0118524 (2009-05-01), Albers et al.
patent: 328597 (1976-03-01), None
patent: 347551 (1979-01-01), None
patent: 2260397 (2000-07-01), None
patent: 42559 (1998-10-01), None
patent: 1143384 (1997-02-01), None
patent: 2332038 (1974-01-01), None
patent: 3839017 (1990-05-01), None
patent: 3839017 (1990-05-01), None
patent: 40 08 066 (1991-08-01), None
patent: 100 24 420 (2001-11-01), None
patent: 10 2006 012 866 (2007-04-01), None
patent: 0 175 468 (1986-03-01), None
patent: 0 189 610 (1986-08-01), None
patent: 0 283 140 (1988-09-01), None
patent: 0 283 140 (1988-09-01), None
patent: 0 292 846 (1988-11-01), None
patent: 0 255 824 (1990-01-01), None
patent: 0 442 184 (1991-08-01), None
patent: 0632267 (1995-01-01), None
patent: 1 419 780 (2004-05-01), None
patent: 2 103 302 (1972-04-01), None
patent: 2 527 934 (1983-12-01), None
patent: 2 651 148 (1991-03-01), None
patent: 2 651 149 (1991-03-01), None
patent: 2 686 028 (1993-07-01), None
patent: 2 690 630 (1993-11-01), None
patent: 2 694 208 (1994-02-01), None
patent: 476134 (1937-12-01), None
patent: 485614 (1938-05-01), None
patent: 490433 (1938-08-01), None
patent: 493948 (1938-10-01), None
patent: 2 033 745 (1980-05-01), None
patent: 1 604 554 (1981-12-01), None
patent: 2 148 713 (1985-06-01), None
patent: 2 197 199 (1988-05-01), None
patent: 2 218 984 (1989-11-01), None
patent: 2 221 843 (1990-02-01), None
patent: 59-14793 (1984-01-01), None
patent: 60-33088 (1985-02-01), None
patent: 61-192797 (1986-08-01), None
patent: 1-252294 (1989-10-01), None
patent: 2-25447 (1990-01-01), None
patent: 6-116585 (1994-04-01), None
patent: 6-293895 (1994-10-01), None
patent: 9-510091 (1997-10-01), None
patent: 39-05538 (2003-07-01), None
patent: WO 86/03781 (1986-07-01), None
patent: WO 87/02247 (1987-04-01), None
patent: WO 87/03899 (1987-07-01), None
patent: WO 88/08444 (1988-11-01), None
patent: WO 89/11521 (1989-11-01), None
patent: WO 90/12509 (1990-11-01), None
patent: WO 90/13656 (1990-11-01), None
patent: WO 91/16443 (1991-10-01), None
patent: WO 95/24459 (1995-09-01), None
patent: WO 95/24459 (1995-09-01), None
patent: WO 98/18952 (1998-05-01), None
patent: WO 00/73254 (2000-12-01), None
patent: WO 01/03810 (2001-01-01), None
patent: WO 2007/107260 (2007-09-01), None
Product Specifcations for EPAX 4020 EE, 5500 EE, 6000 EE, 6015 EE.
Dam et al.,“Efficacy of concentrated n-3 Fatty Acids in hypertriglyceridaemia—A Comparison with Gemfibrozil”, Clin. Drug Invest., pp. 175-181, 2001.
Omacor prescribing information from the FDA website.
EPAX Product Material.
Omacor Product Material.
ABE, Y. et al. “Soluble Cell Adhesion Molecules in Hypertriglyceridemia and Potential Significance on Monocyte Adhesion,”Arteriosclerosis, Thrombosis, and Vascular Biology(1998), 18(5), 723-731.
Abhyankar, B. “Further reduction in mortality following myocardial infarction,”J. Hospital Medicine(2002), 63(10), 610-614.
Adachi, S. et al. “Acidolysis of Sardine Oil by Lipase to Concentrate Eicosapentaenoic and Docosahexaenoic Acids in Glycerides,”J. Ferment. Bioeng.(1993), 75(4), 259-264.
Bimbo, A. P. “Guidelines for characterizing food-grade fish oil,”Inform(1998), 9(5), 473-483.
Bønaa, K. H. et al. “Effect of Eicosapentaenoic and Docosahexaenoic Acids on Blood Pressure in Hypertension,”New England J. of Medicine(1990), 322, 795-801.
Breivik, H. et al. “Preparation of Highly Purified Concentrates of Eicosapentaenoic Acid and Docosahexaenoic Acid,”JAOCS(1997), 74(11), 1425-1429.
Bryhn, M. et al. “The bioavailability and pharmacodynamics of different concentrations of omega-3 acid ethyl esters,”Prostaglandins, Leukotrienes and Essential Fatty Acids(2006), 75, 19-24.
Calabresi, L. et al. “Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses,”Atherosclerosis(2000), 148(2), 387-396.
Chan, D. C. et al “Regulatory Effects of HMG CoA Reductase Inhibitor and Fish Oils on Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Male Subject
Breivik Harald
Thorstad Olav
Carr Deborah D
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Pronova Biopharma Norge AS
LandOfFree
Pharmaceutical composition comprising low concentrations of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition comprising low concentrations of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising low concentrations of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4156048